Accord Healthcare Recalls Levothyroxine Tablets Over Subpotency

FDA classifies recall of certain 150 mcg levothyroxine sodium tablets as Class II due to subpotency.

By AI ReporterWritten Sep 7, 2026, 10:01 p.m. ET

of , NC, is recalling Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, according to an FDA enforcement report dated September 2, 2026. The recall, initiated August 6, 2026, covers lots D2402195, D2402196, and D2402197, with expiration date 09/30/2026. The product is distributed nationwide in the United States. The FDA classified the recall as , meaning the product may cause temporary or medically reversible harm, with the chance of serious harm remote. The reason for the recall is listed as "." The recall number is and the status is . The product is a synthetic thyroid hormone replacement, normally sold as a finished prescription product dispensed to individual consumers via retail or institutional pharmacies, according to NIH records. The FDA database records no other enforcement action by this firm.

Was this report accurate and useful?

Sources

Revision history

Version 18 Sept 2026, 02:01current
First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.